Pat Albert Fetaya

Head, US Business Development at Servier Pharmaceuticals

Pat Albert Fetaya has a diverse work experience spanning multiple industries. Pat Albert is currently the Head of US Business Development at Servier Pharmaceuticals, where they are responsible for shaping and leading the company's business development function, with a focus on expanding their portfolio in oncology. Prior to this, Pat was a Board Member at SAVE, a non-profit animal shelter dedicated to protecting homeless companion animals.

Before joining Servier Pharmaceuticals and SAVE, Pat worked at SUN PHARMA, where they held various roles in business development and strategy for the company's US Specialty Pharma business. Pat Albert was responsible for leading the business development function, handling transactions, and conducting commercial assessments across different therapeutic areas.

Earlier in their career, Pat worked at Bristol-Myers Squibb as a Director in the Global Commercialization team, where they were involved in marketing strategy and operational model design for various therapeutic areas. Pat Albert also worked at Johnson & Johnson as an Associate Director in New Business Development, focusing on strategy development and transaction leadership for externally sourced revenue growth opportunities.

Pat has also worked at Avaya, NewView Technologies Inc, and SRI International in roles related to corporate development, business development, and technology commercialization. Overall, their work experience showcases a strong background in business development, strategy, and commercial assessments across different industries.

Pat Albert Fetaya holds a Bachelor of Arts degree in Chemistry from The City University of New York - Queens College. They also obtained a Master of Science Engineering degree in Wharton Business from the University of Pennsylvania. In addition, Pat earned an MBA in Finance from Rutgers Business School. They have a certification from the BoardConnect Board Training Program, acquired in 2021. Pat also completed a Mini-MBA in Digital Marketing from Rutgers Business School in 2015.

Links

Previous companies

SRI International logo
Avaya logo
Johnson & Johnson logo
Bristol-Myers Squibb logo

Timeline

  • Head, US Business Development

    October, 2021 - present

View in org chart